Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Cell Reports
|
December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
Timothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
Dilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancer
Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran, et al.
Nature Communications
|
September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer
Kevin Chang, Henry M Delavan, Elizabeth Yip, et al.
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
JCO Precision Oncology
|
June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
Nima Almassi, Karissa Whiting, Antoun Toubaji, et al.
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
JCO Precision Oncology
|
May 1, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer
Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Samuel A Funt, Michael Lattanzi, Karissa Whiting, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Cell Reports
|
December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
Timothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
Dilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancer
Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran, et al.
Nature Communications
|
September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer
Kevin Chang, Henry M Delavan, Elizabeth Yip, et al.
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
JCO Precision Oncology
|
June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
Nima Almassi, Karissa Whiting, Antoun Toubaji, et al.
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
JCO Precision Oncology
|
May 1, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer
Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Samuel A Funt, Michael Lattanzi, Karissa Whiting, et al.
Page
of 5